All In Biotech

Drug Trial Radar · NCT04855292

A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes

A Randomized, Double-blind, Placebo-controlled, Multiple Dose Phase Ib Study in Overweight/Obese Subjects Without Diabetes to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of TG103 Injection

Last checked: Nov 19, 2026Latest source record: Jun 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Jul 1, 2021

Primary completion

Dec 1, 2022

Study completion Jan 1, 2023

Sponsor

Sponsor type
Industry
First posted
Apr 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess the safety and tolerability of multiple doses of TG103 injection in overweight/obese subjects without diabetes

Conditions

  • Diabetes

Interventions

  • TG103 injectionDrug

    TG103 injection, SC, once weekly

  • PlaceboDrug

    Placebo control, SC, once weekly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability assessed by incidence and severity of adverse eventsTime frame: Up to 99 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Gao Huanhuan

    Beijingcun, Hebei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.